Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May;20(5):497-530.
doi: 10.6004/jnccn.2022.0025.

Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

David S Ettinger  1 , Douglas E Wood  2 , Dara L Aisner  3 , Wallace Akerley  4 , Jessica R Bauman  5 , Ankit Bharat  6 , Debora S Bruno  7 , Joe Y Chang  8 , Lucian R Chirieac  9 , Thomas A D'Amico  10 , Malcolm DeCamp  11 , Thomas J Dilling  12 , Jonathan Dowell  13 , Scott Gettinger  14 , Travis E Grotz  15 , Matthew A Gubens  16 , Aparna Hegde  17 , Rudy P Lackner  18 , Michael Lanuti  19 , Jules Lin  20 , Billy W Loo  21 , Christine M Lovly  22 , Fabien Maldonado  22 , Erminia Massarelli  23 , Daniel Morgensztern  24 , Thomas Ng  25 , Gregory A Otterson  26 , Jose M Pacheco  3 , Sandip P Patel  27 , Gregory J Riely  28 , Jonathan Riess  29 , Steven E Schild  15 , Theresa A Shapiro  1 , Aditi P Singh  30 , James Stevenson  7 , Alda Tam  8 , Tawee Tanvetyanon  12 , Jane Yanagawa  31 , Stephen C Yang  1 , Edwin Yau  32 , Kristina Gregory  33 , Miranda Hughes  33
Affiliations

Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

David S Ettinger et al. J Natl Compr Canc Netw. 2022 May.

Update in

  • Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology.
    Riely GJ, Wood DE, Ettinger DS, Aisner DL, Akerley W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac LR, DeCamp M, Desai AP, Dilling TJ, Dowell J, Durm GA, Gettinger S, Grotz TE, Gubens MA, Juloori A, Lackner RP, Lanuti M, Lin J, Loo BW, Lovly CM, Maldonado F, Massarelli E, Morgensztern D, Mullikin TC, Ng T, Owen D, Owen DH, Patel SP, Patil T, Polanco PM, Riess J, Shapiro TA, Singh AP, Stevenson J, Tam A, Tanvetyanon T, Yanagawa J, Yang SC, Yau E, Gregory KM, Hang L. Riely GJ, et al. J Natl Compr Canc Netw. 2024 May;22(4):249-274. doi: 10.6004/jnccn.2204.0023. J Natl Compr Canc Netw. 2024. PMID: 38754467

Abstract

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) provide recommended management for patients with NSCLC, including diagnosis, primary treatment, surveillance for relapse, and subsequent treatment. Patients with metastatic lung cancer who are eligible for targeted therapies or immunotherapies are now surviving longer. This selection from the NCCN Guidelines for NSCLC focuses on targeted therapies for patients with metastatic NSCLC and actionable mutations.

PubMed Disclaimer

References

MeSH terms